Indication | Research | Preclinical | Phase I | Phase II | Phase III | |
---|---|---|---|---|---|---|
CKD-943**
- Opioid Receptor Kappa agonist
|
Pain, Uremic pruritus |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
||||
CKD-516
- Tublin Polymerization inhibitor
|
Colorectal cancer |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
||||
CKD-581
- Pan-HDAC inhibitor
|
Multiple myeloma |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
||||
CKD-506 - HDAC6 inhibitor |
Autoimmune disease |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
||||
CKD-504 - HDAC6 inhibitor |
Huntington’s disease |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
||||
CKD-508 - CETP inhibitor |
Dyslipidemia |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
||||
CKD-510 - HDAC6 inhibitor |
Rare disease |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
CKD-943** : License-in from Cara Therapeutics in the US
Indication | Research | Preclinical | Phase I | Phase II | Phase III | |
---|---|---|---|---|---|---|
CKD-11101 - NESP/ARANESP Biosimilar (2nd generation of EPO) |
Anemia(Abroad) |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
||||
CKD-701 - Lucentis Biosimilar |
AMD |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
||||
CKD-702 - Bispecific antibody |
Cancer |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
||||
CKD-971*
- IFN-alpha kinoid
|
Lupus |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Indication | Research | Preclinical | Phase I | Phase II | Phase III | |
---|---|---|---|---|---|---|
CKD-398 |
Diabetes |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
||||
CKD-391 |
Dyslipidemia |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
||||
CKD-386 |
Dyslipidemia/Hypertension |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
||||
CKD-841 - Sustained release injection |
Cancer |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
||||
CKD-396 |
Diabetes |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
||||
CKD-333 |
Dyslipidemia/Hypertension |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
||||
CKD-351 |
Glaucoma |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
||||
CKD-491 |
Periodontitis |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
||||
CKD-497 |
Bronchitis |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
||||
CKD-495 |
Gastritis |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
||||
CKD-385 |
Hypertension/Heart failure/Angina pectoris |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |